EP0871445A4 - Composition for treating pain - Google Patents

Composition for treating pain

Info

Publication number
EP0871445A4
EP0871445A4 EP96943584A EP96943584A EP0871445A4 EP 0871445 A4 EP0871445 A4 EP 0871445A4 EP 96943584 A EP96943584 A EP 96943584A EP 96943584 A EP96943584 A EP 96943584A EP 0871445 A4 EP0871445 A4 EP 0871445A4
Authority
EP
European Patent Office
Prior art keywords
composition
treating pain
pain
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96943584A
Other languages
German (de)
French (fr)
Other versions
EP0871445A1 (en
Inventor
Charles H Mitch
Harlan E Shannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0871445A1 publication Critical patent/EP0871445A1/en
Publication of EP0871445A4 publication Critical patent/EP0871445A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP96943584A 1995-12-07 1996-12-05 Composition for treating pain Withdrawn EP0871445A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US829995P 1995-12-07 1995-12-07
US8299P 1995-12-07
PCT/US1996/019309 WO1997020561A1 (en) 1995-12-07 1996-12-05 Composition for treating pain

Publications (2)

Publication Number Publication Date
EP0871445A1 EP0871445A1 (en) 1998-10-21
EP0871445A4 true EP0871445A4 (en) 2001-01-10

Family

ID=21730869

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96943584A Withdrawn EP0871445A4 (en) 1995-12-07 1996-12-05 Composition for treating pain

Country Status (13)

Country Link
EP (1) EP0871445A4 (en)
JP (1) JP2000501709A (en)
KR (1) KR19990071976A (en)
CN (1) CN1208349A (en)
AU (1) AU705031B2 (en)
CA (1) CA2238815A1 (en)
CZ (1) CZ174698A3 (en)
EA (1) EA199800533A1 (en)
IL (1) IL124419A0 (en)
NO (1) NO982562L (en)
NZ (1) NZ324988A (en)
PL (1) PL327137A1 (en)
WO (1) WO1997020561A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046227A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Composition for treating pain
ATE248166T1 (en) 1999-06-04 2003-09-15 Lilly Co Eli 7-OXO-2-AZABICYCLO(2.2.1)HEPTANES AS SELECTIVE MUSCARINE RECEPTOR ANTAGONISTS
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (en) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Liquid-filled dosage form to prevent immediate release abuse
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307142A1 (en) * 1987-09-10 1989-03-15 Merck Sharp & Dohme Ltd. Thiadiazoles useful in the treatment of senile dementia
WO1994020496A1 (en) * 1993-03-05 1994-09-15 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1995014460A1 (en) * 1993-11-23 1995-06-01 Euro-Celtique S.A. Opioid formulations for treating pain
WO1995025511A1 (en) * 1994-03-18 1995-09-28 Bayer Corporation Low dosage ketoprofen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) * 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US5260293A (en) * 1988-01-30 1993-11-09 Merck Sharp & Dohme Limited Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
IL89351A0 (en) * 1988-03-14 1989-09-10 Lundbeck & Co As H 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307142A1 (en) * 1987-09-10 1989-03-15 Merck Sharp & Dohme Ltd. Thiadiazoles useful in the treatment of senile dementia
WO1994020496A1 (en) * 1993-03-05 1994-09-15 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1995014460A1 (en) * 1993-11-23 1995-06-01 Euro-Celtique S.A. Opioid formulations for treating pain
WO1995025511A1 (en) * 1994-03-18 1995-09-28 Bayer Corporation Low dosage ketoprofen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9720561A1 *

Also Published As

Publication number Publication date
CN1208349A (en) 1999-02-17
IL124419A0 (en) 1998-12-06
CZ174698A3 (en) 1998-10-14
NZ324988A (en) 1999-08-30
KR19990071976A (en) 1999-09-27
WO1997020561A1 (en) 1997-06-12
NO982562D0 (en) 1998-06-04
PL327137A1 (en) 1998-11-23
CA2238815A1 (en) 1997-06-12
NO982562L (en) 1998-07-10
EP0871445A1 (en) 1998-10-21
EA199800533A1 (en) 1999-02-25
AU1279197A (en) 1997-06-27
JP2000501709A (en) 2000-02-15
AU705031B2 (en) 1999-05-13

Similar Documents

Publication Publication Date Title
EP0874828A4 (en) Composition for treating pain
ZA96740B (en) Skin treatment composition
GB9507130D0 (en) Hair treatment composition
GB2298440B (en) Well treatment
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) Method for treating pain
AU5439996A (en) Compositions and methods for treating pain
AU9035498A (en) Method for treating pain
GB9411080D0 (en) Treatment
IL122718A0 (en) Methods for treating diabetes
EP0703282A3 (en) Composition for surface treatment
ZA952356B (en) Skin treatment composition
GB9803642D0 (en) Hair treatment composition
GB9519033D0 (en) Treatment
IL126064A0 (en) Method for treating pain
IL124419A0 (en) Composition for treating pain
ZA952121B (en) Skin treatment composition
IL124786A0 (en) Method for treating pain
AU9034798A (en) Method for treating pain
EP0845975A4 (en) Hair treatment composition
EP1007041A4 (en) Composition for treating pain
AU7247898A (en) Composition for treating pain
GB9405046D0 (en) Skin treatment composition
GB9507482D0 (en) Skin treatment composition
GB9510065D0 (en) Treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980603

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 20001127

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

18W Application withdrawn

Withdrawal date: 20001201